Dr. Thomas Flaig highlights the importance of multidisciplinary care and clinical trials in guiding personalized bladder ...

An expert discusses the need to tailor treatment duration in bladder cancer, balancing improved outcomes with toxicity and ...

A phase 2 study evaluated the efficacy and safety of adding pembrolizumab to trimodal therapy as a bladder-sparing approach for muscle-invasive bladder cancer (MIBC).

Explore surgical options for metastatic bladder cancer, including radical cystectomy and metastasectomy. Learn how surgery ...

A refined liquid biopsy that accounts for age-related background mutations has enabled clinicians to identify patients with ...

A new study from Stanford researchers reveals a non-invasive urine test that can accurately detect residual bladder cancer ...

A groundbreaking noninvasive urine test is transforming how doctors predict bladder cancer treatment outcomes. This ...

Bladder cancer is probably a bit further down your list of concerns than other cancers and conditions. Still, knowing the ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Johnson & Johnson (NYSE:JNJ) reported first in human Phase 1 ...

The MarketWatch News Department was not involved in the creation of this content. Cerberus Ventures leads financing alongside five physician users of Virchow's biopsy technologies LA JOLLA, ...

Lung cancer is the leading cause of death from cancer. It kills more people in the U.S. than breast, prostate, and colon cancer combined. When lung adenocarcinoma, the most common primary lung cancer ...